Key facts
- CureBay’s last known valuation is $67.0M (May 2025).
- It has raised $36.2M; the latest was Debt - General ($1.1M) in Aug 2025.
- Notable investors include British International Investment, Bertelsmann India Investments, Elevar Equity, InCred Wealth, Stride Ventures — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for CureBay
- ·The full record, as it builds
Funding rounds
No funding rounds for CureBay are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CureBay
Operator of online eClinics intended to bridge the gap in the healthcare system and patients. The company's eClinics and healthcare system is accessible to any person anywhere and everywhere and can connect to expert doctors and consult them for their concerns as well as offers other healthcare support, enabling patients to get a consultation from doctors at a nominal cost.
- Sector
- Healthcare
- HQ
- Bhubaneswar, India
- Founded
- 2020
- Employees
- 40
- Website
- curebay.com/
- Ownership
- Privately Held (backing)
CureBay doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CureBay shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CureBay in its N-PORT filings yet. We sweep new filings monthly.